Intelligent Bio Solutions Inc. Files 8-K

Ticker: INBS · Form: 8-K · Filed: May 16, 2025 · CIK: 1725430

Sentiment: neutral

Topics: disclosure, financial-statements, exhibits

TL;DR

IBSI filed an 8-K on 5/16 for events on 5/15, including financial docs.

AI Summary

Intelligent Bio Solutions Inc. filed an 8-K on May 16, 2025, reporting events as of May 15, 2025. The filing is a Regulation FD Disclosure and includes Financial Statements and Exhibits. The company, formerly known as GBS Inc. and Glucose Biosensor Systems (Greater China) Holdings, Inc., is incorporated in Delaware and headquartered in New York.

Why It Matters

This 8-K filing indicates a regulatory disclosure and the submission of financial statements and exhibits, which are important for investors to understand the company's current status and financial health.

Risk Assessment

Risk Level: low — This filing is a routine 8-K for disclosures and financial statements, not indicating any immediate significant operational or financial distress.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.

What was Intelligent Bio Solutions Inc. formerly known as?

Intelligent Bio Solutions Inc. was formerly known as GBS Inc. and Glucose Biosensor Systems (Greater China) Holdings, Inc.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on May 15, 2025.

On what date was this 8-K filed?

This 8-K was filed on May 16, 2025.

Where is Intelligent Bio Solutions Inc. headquartered?

Intelligent Bio Solutions Inc. is headquartered at 135 West 41st Street, 5th Floor, New York, NY 10036.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 16, 2025 regarding INTELLIGENT BIO SOLUTIONS INC. (INBS).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing